Literature DB >> 24728833

Diverse mutational pathways converge on saturable chloroquine transport via the malaria parasite's chloroquine resistance transporter.

Robert L Summers1, Anurag Dave, Tegan J Dolstra, Sebastiano Bellanca, Rosa V Marchetti, Megan N Nash, Sashika N Richards, Valerie Goh, Robyn L Schenk, Wilfred D Stein, Kiaran Kirk, Cecilia P Sanchez, Michael Lanzer, Rowena E Martin.   

Abstract

Mutations in the chloroquine resistance transporter (PfCRT) are the primary determinant of chloroquine (CQ) resistance in the malaria parasite Plasmodium falciparum. A number of distinct PfCRT haplotypes, containing between 4 and 10 mutations, have given rise to CQ resistance in different parts of the world. Here we present a detailed molecular analysis of the number of mutations (and the order of addition) required to confer CQ transport activity upon the PfCRT as well as a kinetic characterization of diverse forms of PfCRT. We measured the ability of more than 100 variants of PfCRT to transport CQ when expressed at the surface of Xenopus laevis oocytes. Multiple mutational pathways led to saturable CQ transport via PfCRT, but these could be separated into two main lineages. Moreover, the attainment of full activity followed a rigid process in which mutations had to be added in a specific order to avoid reductions in CQ transport activity. A minimum of two mutations sufficed for (low) CQ transport activity, and as few as four conferred full activity. The finding that diverse PfCRT variants are all limited in their capacity to transport CQ suggests that resistance could be overcome by reoptimizing the CQ dosage.

Entities:  

Keywords:  Xenopus oocytes; drug resistance; evolutionary biochemistry

Mesh:

Substances:

Year:  2014        PMID: 24728833      PMCID: PMC4035986          DOI: 10.1073/pnas.1322965111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  57 in total

1.  Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum.

Authors:  M B Reed; K J Saliba; S R Caruana; K Kirk; A F Cowman
Journal:  Nature       Date:  2000-02-24       Impact factor: 49.962

2.  Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance.

Authors:  D A Fidock; T Nomura; A K Talley; R A Cooper; S M Dzekunov; M T Ferdig; L M Ursos; A B Sidhu; B Naudé; K W Deitsch; X Z Su; J C Wootton; P D Roepe; T E Wellems
Journal:  Mol Cell       Date:  2000-10       Impact factor: 17.970

3.  Coomassie staining as loading control in Western blot analysis.

Authors:  Charlotte Welinder; Lars Ekblad
Journal:  J Proteome Res       Date:  2011-02-03       Impact factor: 4.466

4.  Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT are associated with chloroquine resistance and unique stereospecific quinine and quinidine responses in Plasmodium falciparum.

Authors:  Roland A Cooper; Michael T Ferdig; Xin-Zhuan Su; Lyann M B Ursos; Jianbing Mu; Takashi Nomura; Hisashi Fujioka; David A Fidock; Paul D Roepe; Thomas E Wellems
Journal:  Mol Pharmacol       Date:  2002-01       Impact factor: 4.436

5.  The antimalarial ferroquine: role of the metal and intramolecular hydrogen bond in activity and resistance.

Authors:  Faustine Dubar; Timothy J Egan; Bruno Pradines; David Kuter; Kanyile K Ncokazi; Delphine Forge; Jean-François Paul; Christine Pierrot; Hadidjatou Kalamou; Jamal Khalife; Eric Buisine; Christophe Rogier; Hervé Vezin; Isabelle Forfar; Christian Slomianny; Xavier Trivelli; Sergey Kapishnikov; Leslie Leiserowitz; Daniel Dive; Christophe Biot
Journal:  ACS Chem Biol       Date:  2011-01-07       Impact factor: 5.100

6.  Similar efficacy and tolerability of double-dose chloroquine and artemether-lumefantrine for treatment of Plasmodium falciparum infection in Guinea-Bissau: a randomized trial.

Authors:  Johan Ursing; Poul-Erik Kofoed; Amabelia Rodrigues; Daniel Blessborn; Rikke Thoft-Nielsen; Anders Björkman; Lars Rombo
Journal:  J Infect Dis       Date:  2011-01-01       Impact factor: 5.226

7.  Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations.

Authors:  Amar Bir Singh Sidhu; Dominik Verdier-Pinard; David A Fidock
Journal:  Science       Date:  2002-10-04       Impact factor: 47.728

8.  Protecting the malaria drug arsenal: halting the rise and spread of amodiaquine resistance by monitoring the PfCRT SVMNT type.

Authors:  Juliana M Sa; Olivia Twu
Journal:  Malar J       Date:  2010-12-23       Impact factor: 2.979

9.  Sequence and gene expression of chloroquine resistance transporter (pfcrt) in the association of in vitro drugs resistance of Plasmodium falciparum.

Authors:  Wanna Chaijaroenkul; Stephen A Ward; Mathirut Mungthin; David Johnson; Andrew Owen; Patrick G Bray; Kesara Na-Bangchang
Journal:  Malar J       Date:  2011-02-15       Impact factor: 2.979

10.  Frog oocytes to unveil the structure and supramolecular organization of human transport proteins.

Authors:  Marc J Bergeron; Rajendra Boggavarapu; Marcel Meury; Zöhre Ucurum; Luc Caron; Paul Isenring; Matthias A Hediger; Dimitrios Fotiadis
Journal:  PLoS One       Date:  2011-07-07       Impact factor: 3.240

View more
  35 in total

1.  Temporal and seasonal changes of genetic polymorphisms associated with altered drug susceptibility to chloroquine, lumefantrine, and quinine in Guinea-Bissau between 2003 and 2012.

Authors:  Irina Tatiana Jovel; Poul-Erik Kofoed; Lars Rombo; Amabelia Rodrigues; Johan Ursing
Journal:  Antimicrob Agents Chemother       Date:  2014-11-24       Impact factor: 5.191

2.  Characterization of the chloroquine resistance transporter homologue in Toxoplasma gondii.

Authors:  Sally D Warring; Zhicheng Dou; Vern B Carruthers; Geoffrey I McFadden; Giel G van Dooren
Journal:  Eukaryot Cell       Date:  2014-05-23

3.  Balancing drug resistance and growth rates via compensatory mutations in the Plasmodium falciparum chloroquine resistance transporter.

Authors:  Ines Petersen; Stanislaw J Gabryszewski; Geoffrey L Johnston; Satish K Dhingra; Andrea Ecker; Rebecca E Lewis; Mariana Justino de Almeida; Judith Straimer; Philipp P Henrich; Eugene Palatulan; David J Johnson; Olivia Coburn-Flynn; Cecilia Sanchez; Adele M Lehane; Michael Lanzer; David A Fidock
Journal:  Mol Microbiol       Date:  2015-05-20       Impact factor: 3.501

4.  Malaria parasites fine-tune mutations to resist drugs.

Authors:  Leann Tilley; Philip J Rosenthal
Journal:  Nature       Date:  2019-12       Impact factor: 49.962

5.  Phosphomimetic substitution at Ser-33 of the chloroquine resistance transporter PfCRT reconstitutes drug responses in Plasmodium falciparum.

Authors:  Cecilia P Sanchez; Sonia Moliner Cubel; Britta Nyboer; Monika Jankowska-Döllken; Christine Schaeffer-Reiss; Daniel Ayoub; Gabrielle Planelles; Michael Lanzer
Journal:  J Biol Chem       Date:  2019-07-08       Impact factor: 5.157

6.  Functional Comparison of 45 Naturally Occurring Isoforms of the Plasmodium falciparum Chloroquine Resistance Transporter (PfCRT).

Authors:  Paul S Callaghan; Matthew R Hassett; Paul D Roepe
Journal:  Biochemistry       Date:  2015-08-06       Impact factor: 3.162

7.  Iron is a substrate of the Plasmodium falciparum chloroquine resistance transporter PfCRT in Xenopus oocytes.

Authors:  Naziha Bakouh; Sebastiano Bellanca; Britta Nyboer; Sonia Moliner Cubel; Zoubida Karim; Cecilia P Sanchez; Wilfred D Stein; Gabrielle Planelles; Michael Lanzer
Journal:  J Biol Chem       Date:  2017-08-02       Impact factor: 5.157

8.  High-Dose Chloroquine for Uncomplicated Plasmodium falciparum Malaria Is Well Tolerated and Causes Similar QT Interval Prolongation as Standard-Dose Chloroquine in Children.

Authors:  Johan Ursing; Lars Rombo; Staffan Eksborg; Lena Larson; Anita Bruvoll; Joel Tarning; Amabelia Rodrigues; Poul-Erik Kofoed
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

9.  Mechanistic basis for multidrug resistance and collateral drug sensitivity conferred to the malaria parasite by polymorphisms in PfMDR1 and PfCRT.

Authors:  Sarah Heckmatt Shafik; Sashika Natasha Richards; Ben Corry; Rowena Elizabeth Martin
Journal:  PLoS Biol       Date:  2022-05-04       Impact factor: 9.593

10.  Mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, enlarge the parasite's food vacuole and alter drug sensitivities.

Authors:  Serena Pulcini; Henry M Staines; Andrew H Lee; Sarah H Shafik; Guillaume Bouyer; Catherine M Moore; Daniel A Daley; Matthew J Hoke; Lindsey M Altenhofen; Heather J Painter; Jianbing Mu; David J P Ferguson; Manuel Llinás; Rowena E Martin; David A Fidock; Roland A Cooper; Sanjeev Krishna
Journal:  Sci Rep       Date:  2015-09-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.